| Year |
Citation |
Score |
| 2009 |
Jiang Z, Ordóñez R. On-line robust trajectory generation on approach and landing for reusable launch vehicles Automatica. 45: 1668-1678. DOI: 10.1016/J.Automatica.2009.03.017 |
0.364 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Hurvitz SA, Andre F, Jiang Z, Shao Z, Mano MS, Neciosup SP, Tseng LM, Zhang Q, Shen K, Liu D, Dreosti LM, Burris HA, Toi M, Buyse ME, Cabaribere D, et al. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial. The Lancet. Oncology. 16: 816-29. PMID 26092818 DOI: 10.1016/S1470-2045(15)00051-0 |
0.23 |
|
| 2017 |
Toi M, Shao Z, Hurvitz S, Tseng LM, Zhang Q, Shen K, Liu D, Feng J, Xu B, Wang X, Lee KS, Ng TY, Ridolfi A, Noel-Baron F, Ringeisen F, ... Jiang Z, et al. Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1. Breast Cancer Research : Bcr. 19: 47. PMID 28399902 DOI: 10.1186/s13058-017-0839-0 |
0.23 |
|
| 2021 |
Yuan Y, Zhang S, Yan M, Yin Y, Song Y, Jiang Z. Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study. Annals of Translational Medicine. 9: 831. PMID 34164465 DOI: 10.21037/atm-20-8252 |
0.23 |
|
| 2017 |
Xu B, Shao Z, Wang S, Jiang Z, Hu X, Zhang X, Li XR, Liu J, Li M, Wang S. Treatment patterns and patient profiles for docetaxel-based adjuvant chemotherapy in early-stage breast cancer in China: A pooled analysis of four observational studies. Journal of Clinical Oncology. 35: e12017-e12017. DOI: 10.1200/JCO.2017.35.15_SUPPL.E12017 |
0.224 |
|
| 2011 |
Xu B, Jiang Z, Kim SB, Yu S, Feng J, Malzyner A, Del Giglio A, Chung HC, Shen LJ, Pen DL. Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial. Breast Cancer (Tokyo, Japan). 18: 203-12. PMID 21465229 DOI: 10.1007/s12282-011-0260-y |
0.223 |
|
| 2009 |
GUAN Z, LI QL, FENG F, JIANG Z, SHEN Z, YU S, FEN J, HUANG J, YAO Z, BHAR P. Superior efficacy of a Cremophor-free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese patients with metastatic breast cancer Asia-Pacific Journal of Clinical Oncology. 5: 165-174. DOI: 10.1111/j.1743-7563.2009.01235.x |
0.222 |
|
| 2021 |
Li F, Xu F, Li J, Wang T, Bian L, Zhang S, Jiang Z. Pyrotinib versus trastuzumab emtansine for HER2-positive metastatic breast cancer after previous trastuzumab and lapatinib treatment: a real-world study. Annals of Translational Medicine. 9: 103. PMID 33569405 DOI: 10.21037/atm-20-4054 |
0.22 |
|
| 2021 |
Lv H, Yan M, Jiang Z. Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer. Therapeutic Advances in Medical Oncology. 13: 17588359211013326. PMID 33995599 DOI: 10.1177/17588359211013326 |
0.219 |
|
| 2020 |
Yang F, Huang X, Sun C, Li J, Wang B, Yan M, Jin F, Wang H, Zhang J, Fu P, Zeng T, Wang J, Li W, Li Y, Yang M, ... ... Jiang Z, et al. Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population. Bmc Cancer. 20: 255. PMID 32223744 DOI: 10.1186/s12885-020-6639-4 |
0.217 |
|
| 2010 |
Xu B, Jiang Z, Shao Z, Wang J, Feng J, Song S, Chen Z, Gu K, Yu S, Zhang Y, Wang C, Zhang F, Yang J. Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial. Cancer Chemotherapy and Pharmacology. 67: 223-30. PMID 20938664 DOI: 10.1007/s00280-010-1483-x |
0.216 |
|
| 2010 |
Xu B, Shen Z, Jiang Z, Guan Z, Zhang X. A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment. Asia-Pacific Journal of Clinical Oncology. 6: 320-9. PMID 21114782 DOI: 10.1111/j.1743-7563.2010.01323.x |
0.216 |
|
| 2020 |
Bian L, Xu F, Wang T, Zhang H, Cao Y, Jiang Z. Optimized first-line therapy for stage IV breast cancer brings long-term disease-free survival: a case report and biological analysis Translational Breast Cancer Research. 1: 7-7. DOI: 10.21037/tbcr.2020.04.01 |
0.213 |
|
| 2020 |
Jiang Z, Xu B, Yan M, Ouyang Q, Hu X, Li W, Feng JF, Zhang Q, Tong Z, Yan P, Zhu X, Rong S, Zou J. Pyrotinib combined with capecitabine as first-line therapy for HER2-positive metastatic breast cancer: A pooled analysis of three randomized controlled trials. Journal of Clinical Oncology. 38: e13022-e13022. DOI: 10.1200/jco.2020.38.15_suppl.e13022 |
0.213 |
|
| 2018 |
Xu B, Shao Z, Wang S, Jiang Z, Hu X, Zhang X, Li X, Liu J, Li M, Wang S. Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studies. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 30: 327-339. PMID 30046227 DOI: 10.21147/j.issn.1000-9604.2018.03.05 |
0.211 |
|
| 2012 |
Huang H, Jiang Z, Wang T, Zhang S, Bian L, Cao Y, Wu S, Song S. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer. Anti-Cancer Drugs. 23: 718-23. PMID 22739713 DOI: 10.1097/CAD.0b013e328351802e |
0.21 |
|
| 2020 |
Li F, Xu F, Zhang H, Li J, Wang T, Zhang S, Bian L, Hao X, Jiang Z. Analysis of the treatment patterns and safety of early breast cancer patients during the COVID-19 pandemic Translational Breast Cancer Research. 1: 15-15. DOI: 10.21037/tbcr-20-29 |
0.208 |
|
| 2019 |
Jiang Z, Li W, Hu X, Zhang Q, Sun T, Cui S, Wang S, Ouyang Q, Yin Y, Geng C, Tong Z, Cheng Y, Pan Y, Sun Y, Wang H, et al. Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Oncology. PMID 31036468 DOI: 10.1016/S1470-2045(19)30164-0 |
0.208 |
|
| 2017 |
Baselga J, Im SA, Iwata H, Cortés J, De Laurentiis M, Jiang Z, Arteaga CL, Jonat W, Clemons M, Ito Y, Awada A, Chia S, Jagiełło-Gruszfeld A, Pistilli B, Tseng LM, et al. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Oncology. PMID 28576675 DOI: 10.1016/S1470-2045(17)30376-5 |
0.204 |
|
| 2020 |
Zhao W, Bian L, Wang T, Zhang S, Li J, Xu F, Jiang Z. Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 32: 361-369. PMID 32694900 DOI: 10.21147/j.issn.1000-9604.2020.03.07 |
0.204 |
|
| 2004 |
Zhu J, Song S, Jiang Z, Yan J, Lu Q, Huang C, Ye Q. Characterization of COBRA1 in human breast cancer cell lines using a new polyclonal antibody against COBRA1. Iubmb Life. 56: 161-6. PMID 15185750 DOI: 10.1080/15216540410001699826 |
0.204 |
|
| 2020 |
Xu F, Zhang Y, Miao Z, Zeng X, Wu B, Cai L, Liu J, Wang S, Hu X, Zheng W, Chen Z, Yang Q, Jiang Z. Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial. Annals of Translational Medicine. 8: 660. PMID 32566597 DOI: 10.21037/atm-2020-23 |
0.203 |
|
| 2017 |
Zhang P, Sun T, Zhang Q, Yuan Z, Jiang Z, Wang XJ, Cui S, Teng Y, Hu XC, Yang J, Pan H, Tong Z, Li H, Yao Q, Wang Y, et al. Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial. The Lancet. Oncology. PMID 28209298 DOI: 10.1016/S1470-2045(17)30088-8 |
0.202 |
|
| 2019 |
Robertson JFR, Jiang Z, Di Leo A, Ohno S, Pritchard KI, Ellis M, Bradbury I, Campbell C. A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer. Breast Cancer (Tokyo, Japan). PMID 31079343 DOI: 10.1007/s12282-019-00973-4 |
0.201 |
|
| 2013 |
Guan Z, Xu B, DeSilvio ML, Shen Z, Arpornwirat W, Tong Z, Lorvidhaya V, Jiang Z, Yang J, Makhson A, Leung WL, Russo MW, Newstat B, Wang L, Chen G, et al. Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1947-53. PMID 23509322 DOI: 10.1200/JCO.2011.40.5241 |
0.2 |
|
| 2017 |
Li J, Wang S, Wang Y, Wang X, Wang H, Feng J, Zhang Q, Sun T, Ouyang Q, Yin Y, Liu Y, Geng C, Yan M, Jiang Z. Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China. The Oncologist. PMID 28798274 DOI: 10.1634/theoncologist.2017-0088 |
0.199 |
|
| 2019 |
Luo Y, Li W, Jiang Z, Zhang Q, Wang L, Mao Y, Tjan-Heijnen VCG, Im SA, McConnell R, Bejarano S, Fumagalli D, Bines J, Wang B, Garg A, Kirschbrown WP, et al. Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer. Anti-Cancer Drugs. PMID 31305270 DOI: 10.1097/CAD.0000000000000808 |
0.198 |
|
| 2014 |
Zhang H, Wang T, Bian L, Zhou J, Zhang S, Wu S, Song S, Zhang H, Jiang Z. Gemcitabine plus cisplatin versus vinorelbine plus cisplatin in patients with anthracycline- and taxane-pretreated HER2-negative metastatic breast cancer. Journal of Clinical Oncology. 32: e12006-e12006. DOI: 10.1200/JCO.2014.32.15_SUPPL.E12006 |
0.198 |
|
| 2020 |
Wu Y, Han Y, Yu P, Ouyang Q, Yan M, Wang X, Hu X, Jiang Z, Huang T, Tong Z, Wang S, Yin Y, Li H, Yang R, Yang H, et al. Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China. Frontiers in Oncology. 10: 599604. PMID 33643905 DOI: 10.3389/fonc.2020.599604 |
0.197 |
|
| 2019 |
Xu F, Zhang Y, Miao Z, Zeng X, Wu B, Cai L, Liu J, Wang S, Hu X, Zheng W, Chen Z, Yang Q, Jiang Z. Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial. Annals of Translational Medicine. 7: 482. PMID 31700918 DOI: 10.21037/atm.2019.07.95 |
0.195 |
|
| 2009 |
Burstein H, Sun Y, Dirix L, Jiang Z, Paridaens R, Tan A, Awada A, Ranade A, Jiao S, Schwartz G, Powell C, Turnbull K, Vermette J, Zacharchuk C, Badwe R. Gastrointestinal and Cardiovascular Safety Profiles of Neratinib Monotherapy in Patients with Advanced ErbB2-Positive Breast Cancer. Cancer Research. 69: 5096-5096. DOI: 10.1158/0008-5472.Sabcs-09-5096 |
0.194 |
|
| 2016 |
Tian X, Xin M, Luo J, Liu M, Jiang Z. Identification of Genes Involved in Breast Cancer Metastasis by Integrating Protein-Protein Interaction Information with Expression Data. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. PMID 27508455 DOI: 10.1089/Cmb.2015.0206 |
0.192 |
|
| 2019 |
Xu F, Wang X, Jiang Z. A right atrium metastasis of breast cancer after long-term endocrine therapy. Annals of Translational Medicine. 7: 702. PMID 31930103 DOI: 10.21037/atm.2019.09.36 |
0.189 |
|
| 2010 |
Chen W, Jiang Z, Shao Z, Sun Q, Shen K. An economic evaluation of adjuvant trastuzumab therapy in HER2-positive early breast cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. S82-4. PMID 20586989 DOI: 10.1111/j.1524-4733.2009.00634.x |
0.189 |
|
| 2010 |
Burstein HJ, Sun Y, Dirix LY, Jiang Z, Paridaens R, Tan AR, Awada A, Ranade A, Jiao S, Schwartz G, Abbas R, Powell C, Turnbull K, Vermette J, Zacharchuk C, et al. Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1301-7. PMID 20142587 DOI: 10.1200/Jco.2009.25.8707 |
0.188 |
|
| 2014 |
Jiang H, Wang T, Jiang Z. Goserelin plus endocrine treatments maintained long-term clinical benefit in a male patient with advanced breast cancer. World Journal of Surgical Oncology. 12: 393. PMID 25539790 DOI: 10.1186/1477-7819-12-393 |
0.188 |
|
| 2018 |
Xu B, Zhang P, Sun T, Zhang Q, Jiang Z, Yuan Z, Wang X, Cui S, Teng Y, Hu X, Yang J, Pan H, Tong Z, Li H, Yao Q, et al. Phase III multicenter, randomized study of utidelone plus capecitabine versus capecitabine alone for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer. Journal of Clinical Oncology. 36: 1003-1003. DOI: 10.1200/JCO.2018.36.15_suppl.1003 |
0.188 |
|
| 2018 |
Zhang Q, Wang T, Geng C, Zhang Y, Zhang J, Ning Z, Jiang Z. Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 30: 605-612. PMID 30700929 DOI: 10.21147/j.issn.1000-9604.2018.06.05 |
0.187 |
|
| 2012 |
Bian L, Wang T, Liu Y, Zhang H, Song J, Zhang S, Wu S, Song S, Jiang Z. Evaluation of treatment response for breast cancer: are we entering the era of “biological complete remission”? Chinese Journal of Cancer Research. 24: 403-407. DOI: 10.1007/S11670-012-0281-X |
0.187 |
|
| 2019 |
Bian L, Zhang H, Wang T, Zhang S, Song H, Xu M, Yao S, Jiang Z. JS001, an anti-PD-1 mAb for advanced triple negative breast cancer patients after multi-line systemic therapy in a phase I trial. Annals of Translational Medicine. 7: 435. PMID 31700871 DOI: 10.21037/atm.2019.09.08 |
0.186 |
|
| 2021 |
Tian F, Zhang S, Liu C, Han Z, Liu Y, Deng J, Li Y, Wu X, Cai L, Qin L, Chen Q, Yuan Y, Liu Y, Cong Y, Ding B, ... Jiang Z, et al. Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer. Nature Communications. 12: 2536. PMID 33953198 DOI: 10.1038/s41467-021-22913-7 |
0.186 |
|
| 2019 |
Wang T, Wu B, Hu X, Liu J, Zhang T, Li F, Sun B, Cai L, Li X, Chen Z, Yang Q, Jiang Z. A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients. Annals of Translational Medicine. 7: 196. PMID 31205914 DOI: 10.21037/atm.2019.04.10 |
0.186 |
|
| 2020 |
Yan M, Bian L, Hu X, Zhang Q, Ouyang Q, Feng J, Yin Y, Sun T, Tong Z, Wang X, Yao H, Zou J, Zhu X, Jiang Z. Pyrotinib plus capecitabine for human epidermal growth factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study Translational Breast Cancer Research. 1: 13-13. DOI: 10.21037/tbcr-20-25 |
0.185 |
|
| 2019 |
Ma F, Ouyang Q, Li W, Jiang Z, Tong Z, Liu Y, Li H, Yu S, Feng J, Wang S, Hu X, Zou J, Zhu X, Xu B. Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900108. PMID 31430226 DOI: 10.1200/JCO.19.00108 |
0.185 |
|
| 2018 |
Li J, Shao Z, Xu B, Jiang Z, Cui S, Zhang J, Liao N, Jiang J, Wang Y, Ouyang Q, Ying Z. Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study. Medicine. 97: e10350. PMID 29794725 DOI: 10.1097/MD.0000000000010350 |
0.185 |
|
| 2013 |
Liu Y, Liu Q, Wang T, Bian L, Zhang S, Hu H, Li S, Hu Z, Wu S, Liu B, Jiang Z. Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker. Bmc Cancer. 13: 202. PMID 23617715 DOI: 10.1186/1471-2407-13-202 |
0.185 |
|
| 2016 |
Zhou J, Wang T, Liu Y, Zhang H, Zhang S, Bian L, Song S, Jiang Z. The rational use of detection of CTC and serum HER2 ECD for HER2-positive advanced breast cancer patients. Journal of Clinical Oncology. 34: e12084-e12084. DOI: 10.1200/JCO.2016.34.15_SUPPL.E12084 |
0.185 |
|
| 2020 |
Liu Z, Lv M, Li J, Mao Y, Nie G, Zhang J, Geng C, Jin F, Fu P, Zha X, Fan Z, Zhang H, Jiang Z, Wang H. Neoadjuvant chemotherapy versus surgery as the initial option for T3 breast cancer (>5 cm): real-world evidence from the Chinese Society of Clinical Oncology Breast Cancer database Translational Breast Cancer Research. 1: 16-16. DOI: 10.21037/tbcr-20-21 |
0.184 |
|
| 2019 |
Shao Z, Pang D, Yang H, Li W, Wang S, Cui S, Liao N, Wang Y, Wang C, Chang Y, Wang H, Kang S, Jiang Z, Li J, Zhou J, et al. Abstract P6-17-17: Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY) Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P6-17-17 |
0.184 |
|
| 2016 |
Wang T, Zhou J, Zhang S, Bian L, Hu H, Xu C, Hao X, Liu B, Ye Q, Liu Y, Jiang Z. Meaningful interpretation of serum HER2 ECD levels requires clear patient clinical background, and serves several functions in the efficient management of breast cancer patients. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 27109901 DOI: 10.1016/j.cca.2016.04.025 |
0.183 |
|
| 2012 |
Wang T, Zhang S, Zeng M, Lu X, Shen G, Wu S, Song S, Jiang Z. Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Medical Oncology (Northwood, London, England). 29: 56-61. PMID 21264537 DOI: 10.1007/s12032-010-9814-7 |
0.183 |
|
| 2020 |
Li J, Jiang Z. CSCO BC guideline: updates for HER2 positive breast cancer in 2020 Translational Breast Cancer Research. 1: 4-4. DOI: 10.21037/tbcr.2020.03.05 |
0.181 |
|
| 2015 |
Xu B, Hu X, Jiang Z, Li H, Chen J, Cui S, Li Q, Liao N, Liu D, Liu J, Lu J, Shen K, Sun T, Teng Y, Tong Z, et al. National consensus in China on diagnosis and treatment of patients with advanced breast cancer. Annals of Translational Medicine. 3: 242. PMID 26605288 DOI: 10.3978/j.issn.2305-5839.2015.09.47 |
0.181 |
|
| 2019 |
Huang L, Wang X, Zhou L, Di L, Zheng H, Jiang Z, Wang Y, Song X, Feng J, Yu S, Liu Y, Zheng H, Shen K, Tong Z, Shao Z. Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. PMID 31838561 DOI: 10.1007/s00280-019-04000-3 |
0.18 |
|
| 2020 |
Wang S, Li J, Jiang Z, Yin Y, Liu Y, Wang H, Teng Y, Ma L, Song Y, Fu P. Breast cancer patients with low estrogen receptor expression gain no significant survival benefit from endocrine therapy: a real-world study from China Translational Breast Cancer Research. 1: 14-14. DOI: 10.21037/tbcr-20-24 |
0.18 |
|
| 2020 |
Li J, Wang H, Geng C, Liu Z, Lin Y, Nie J, Sun G, Ouyang Q, Wang X, Li X, Liu Y, Chen Q, Fu P, Yao F, Chen J, ... ... Jiang Z, et al. Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020. Eclinicalmedicine. 26: 100503. PMID 32989430 DOI: 10.1016/j.eclinm.2020.100503 |
0.179 |
|
| 2019 |
Shao Z, Pang D, Yang H, Li W, Wang S, Cui S, Liao N, Wang Y, Wang C, Chang YC, Wang H, Kang SY, Seo JH, Shen K, Laohawiriyakamol S, ... Jiang Z, et al. Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial. Jama Oncology. PMID 31647503 DOI: 10.1001/jamaoncol.2019.3692 |
0.175 |
|
| 2020 |
Jin L, Chen K, Tan C, Li J, Luo J, Yang Y, Li Y, Li S, Zhu L, Hu Y, Liu F, You Q, Peng M, Jiang Z, Liu Q. Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer. The Oncologist. PMID 32476192 DOI: 10.1634/theoncologist.2019-1006 |
0.175 |
|
| 2014 |
Bian L, Liu Y, Wang T, Zhang S, Shao Z, Tong Z, Song E, Wang X, Liao N, Jiang Z. [Prediction value for dynamic changes of circulating tumor cell in therapeutic response and prognosis of Chinese metastatic breast cancer patients]. Zhonghua Yi Xue Za Zhi. 94: 265-8. PMID 24731491 |
0.174 |
|
| 2016 |
Zhang S, Li L, Wang T, Bian L, Hu H, Xu C, Liu B, Liu Y, Cristofanilli M, Jiang Z. Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients. Bmc Cancer. 16: 526. PMID 27456503 DOI: 10.1186/s12885-016-2578-5 |
0.174 |
|
| 2014 |
Jiang Z, Li L, Zhang S, Wang T, Liu Y, Bian L, Yuan Y, Qi F, Cristofanilli M. Predictive value of CTCs biomarkers status in patients with metastatic breast cancer (MBC) receiving anti-HER2 therapy. Journal of Clinical Oncology. 32: 628-628. DOI: 10.1200/JCO.2014.32.15_SUPPL.628 |
0.174 |
|
| 2014 |
Xu B, Guan Z, Shen Z, Tong Z, Jiang Z, Yang J, DeSilvio M, Russo M, Leigh M, Ellis C. Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone. Breast Cancer Research : Bcr. 16: 405. PMID 25056500 DOI: 10.1186/s13058-014-0405-y |
0.173 |
|
| 2020 |
Li F, Bian L, Qu Z, Li J, Xu F, Jiang Z. Pyrotinib for metastatic breast cancer after multi-anti-HER2 targeted therapy: a case report Translational Breast Cancer Research. 1: 8-8. DOI: 10.21037/tbcr.2020.04.02 |
0.172 |
|
| 2014 |
Zhou J, Liu Y, Wang T, Zhang H, Du M, Zhang S, Wu S, Song S, Liu B, Zhang H, Jiang Z. [Serum HER2 ECD level and its clinical significance in advanced breast cancer patients with different molecular subtypes]. Zhonghua Yi Xue Za Zhi. 94: 1384-7. PMID 25142988 |
0.172 |
|
| 2010 |
Huang H, Jiang Z, Wang T, Zhang S, Bian L, Cao Y, Wu S, Song S. The retrospective study of single-agent capecitabine in the maintenance treatment of recurrent and metastatic breast cancer. Journal of Clinical Oncology. 28: e11512-e11512. DOI: 10.1200/JCO.2010.28.15_SUPPL.E11512 |
0.172 |
|
| 2020 |
Li X, Bian L, Xu F, Qu Z, Yang F, Jiang Z. Analysis of tumor heterogeneity at the molecular level: a case report of efficacy separation in metastatic breast cancer Translational Breast Cancer Research. 1: 20-20. DOI: 10.21037/tbcr-20-20 |
0.172 |
|
| 2021 |
Xie J, Qi W, Cao L, Tan Y, Huang J, Gu X, Chen B, Shen P, Zhao Y, Zhang Y, Zhao Q, Huang H, Wang Y, Fang H, Jin Z, ... ... Jiang Z, et al. Predictors for Fear of Cancer Recurrence in Breast Cancer Patients Referred to Radiation Therapy During the COVID-19 Pandemic: A Multi-Center Cross-Section Survey. Frontiers in Oncology. 11: 650766. PMID 34381703 DOI: 10.3389/fonc.2021.650766 |
0.171 |
|
| 2010 |
Du M, Qu H, Wang Y, Wu S, Jiang Z. The treatment strategies of breast cancer in patients with renal dysfunction The Chinese-German Journal of Clinical Oncology. 9: 594-596. DOI: 10.1007/s10330-010-0685-3 |
0.171 |
|
| 2016 |
Xu B, Sun T, Zhang Q, Yuan Z, Zhang P, Jia WX, Cui S, Jiang Z, Teng Y, Hu X. Randomized phase III trial of utidelone, a genetically engineered epothilone analog, in combination with capecitabine versus capecitabine alone for metastatic breast cancer patients with previous taxane and anthracycline treatment. Journal of Clinical Oncology. 34: 1004-1004. DOI: 10.1200/JCO.2016.34.15_SUPPL.1004 |
0.171 |
|
| 2020 |
Xu F, Jiang Z. CSCO BC guideline: updates for hormone receptor-positive breast cancer in 2020 Translational Breast Cancer Research. 1: 3-3. DOI: 10.21037/tbcr.2020.03.04 |
0.169 |
|
| 2015 |
Du G, Bian L, Wang T, Xu X, Zhang S, Guo Y, Zhuo J, Song- S, Jiang Z. PTEN loss correlates with the clinical efficacy of lapatinib in HER2 positive metastatic breast cancer with trastuzumab-resistance National Medical Journal of China. 95: 2264-2267. DOI: 10.3760/cma.j.issn.0376-2491.2015.28.005 |
0.168 |
|
| 2021 |
Li P, Cao S, Huang Y, Zhang Y, Liu J, Cai X, Zhou L, Li J, Jiang Z, Ding L, Zheng Z, Li S, Ye Q. A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein. Cell Death Discovery. 7: 198. PMID 34326318 DOI: 10.1038/s41420-021-00580-3 |
0.167 |
|
| 2014 |
Xue J, Jiang Z, Qi F, Lv S, Zhang S, Wang T, Zhang X. Risk of trastuzumab-related cardiotoxicity in early breast cancer patients: a prospective observational study. Journal of Breast Cancer. 17: 363-9. PMID 25548585 DOI: 10.4048/jbc.2014.17.4.363 |
0.167 |
|
| 2021 |
Zhou J, Wang T, Bian L, Li J, Jiang Z. Benefit with re-challenge of immune checkpoint inhibitors in patient with metastatic triple-negative breast cancer: a case report Translational Breast Cancer Research. 2: 14-14. DOI: 10.21037/TBCR-20-71 |
0.166 |
|
| 2020 |
Liu J, Liu Q, Li Y, Li Q, Su F, Yao H, Su S, Wang Q, Jin L, Wang Y, Lau WY, Jiang Z, Song E. Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial. Journal For Immunotherapy of Cancer. 8. PMID 32448804 DOI: 10.1136/jitc-2020-000696 |
0.166 |
|
| 2019 |
Liu D, Lu Q, Wang X, Wang J, Lu N, Jiang Z, Hao X, Li J, Liu J, Cao P, Peng G, Tao Y, Zhao D, He F, Tang L. LSECtin on tumor-associated macrophages enhances breast cancer stemness via interaction with its receptor BTN3A3. Cell Research. PMID 30858559 DOI: 10.1038/s41422-019-0155-6 |
0.165 |
|
| 2020 |
Li Q, Liu J, Jiang Z, Liu Q. CSCO breast cancer guideline: precise, economical and oriental. Science China. Life Sciences. PMID 32548693 DOI: 10.1007/s11427-020-1701-5 |
0.164 |
|
| 2021 |
Xu L, Liu Y, Fan Z, Jiang Z, Liu Y, Ling R, Zhang J, Yu Z, Jin F, Wang C, Cui S, Wang S, Mao D, Han B, Wang T, et al. Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study. Frontiers in Oncology. 11: 606477. PMID 33796452 DOI: 10.3389/fonc.2021.606477 |
0.163 |
|
| 2006 |
Song Y, Song S, Zhang D, Zhang Y, Chen L, Qian L, Shi M, Zhao H, Jiang Z, Guo N. An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy. Bmc Cancer. 6: 298. PMID 17192200 DOI: 10.1186/1471-2407-6-298 |
0.163 |
|
| 2016 |
Ye Q, Bian L, Zhang S, Wang T, Wang Y, Song S, Jiang Z. Association of circulating-free DNA mutation with response of targeted therapy in HER2-positive metastatic breast cancer. Journal of Clinical Oncology. 34: e12083-e12083. DOI: 10.1200/JCO.2016.34.15_SUPPL.E12083 |
0.163 |
|
| 2018 |
Campone M, Im SA, Iwata H, Clemons M, Ito Y, Awada A, Chia S, Jagiełło-Gruszfeld A, Pistilli B, Tseng LM, Hurvitz S, Masuda N, Cortés J, De Laurentiis M, Arteaga CL, ... Jiang Z, et al. Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2. European Journal of Cancer (Oxford, England : 1990). 103: 147-154. PMID 30241001 DOI: 10.1016/j.ejca.2018.08.002 |
0.162 |
|
| 2003 |
Sommer SS, Jiang Z, Feng J, Buzin CH, Zheng J, Longmate J, Jung M, Moulds J, Dritschilo A. ATM missense mutations are frequent in patients with breast cancer. Cancer Genetics and Cytogenetics. 145: 115-20. PMID 12935922 DOI: 10.1016/S0165-4608(03)00119-5 |
0.161 |
|
| 2020 |
Jiang Z. Welcome to Translational Breast Cancer Research Translational Breast Cancer Research. 1: 1-1. DOI: 10.21037/tbcr.2020.03.02 |
0.16 |
|
| 2020 |
Jiang Z, Xu B, Yan M, Ouyang Q, Hu X, Li W, Feng JF, Zhang Q, Tong Z, Yan P, Zhu X, Rong S, Zou J. Pyrotinib plus capecitabine for HER2-positive, trastuzumab-resistant metastatic breast cancer: A pooled analysis of three randomized controlled trials. Journal of Clinical Oncology. 38: 1048-1048. DOI: 10.1200/jco.2020.38.15_suppl.1048 |
0.16 |
|
| 2020 |
Zhu J, Li J, Fan Z, Wang H, Zhang J, Yin Y, Fu P, Geng C, Jin F, Jiang Z, Liu Z. Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy. Annals of Translational Medicine. 8: 992. PMID 32953792 DOI: 10.21037/atm-20-5172 |
0.159 |
|
| 1998 |
Liu X, Song S, Shi C, Xu J, Tang Z, Jiang Z. Establishment of criteria for measuring MDR-1 gene expression level in breast cancer by RT-PCR Chinese Journal of Cancer Research. 10: 126-129. DOI: 10.1007/BF02954022 |
0.158 |
|
| 2016 |
Xiao H, Chen Y, Yuan E, Li W, Jiang Z, Wei L, Su H, Zeng W, Gan Y, Wang Z, Yuan B, Qin S, Leng X, Zhou X, Liu S, et al. Obtaining More Accurate Signals: Spatiotemporal Imaging of Cancer Sites Enabled by a Photoactivatable Aptamer-Based Strategy. Acs Applied Materials & Interfaces. PMID 27550088 DOI: 10.1021/acsami.6b07450 |
0.155 |
|
| 2017 |
Zhang Q, Wang T, Geng C, Zhang Y, Zhang J, Ning Z, Jiang Z. Pilot trial of chidamide, an oral histone deacetylase (HDAC) inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer. Journal of Clinical Oncology. 35: e12543-e12543. DOI: 10.1200/JCO.2017.35.15_SUPPL.E12543 |
0.154 |
|
| 2019 |
Xu F, Sepúlveda MJ, Jiang Z, Wang H, Li J, Yin Y, Liu Z, Roebuck MC, Shortliffe EH, Yan M, Song Y, Geng C, Tang J, Rhee K. Artificial Intelligence Treatment Decision Support For Complex Breast Cancer Among Oncologists With Varying Expertise. Jco Clinical Cancer Informatics. 3: 1-15. PMID 31419181 DOI: 10.1200/CCI.18.00159 |
0.153 |
|
| 2020 |
Jiang Z, Song E, Wang X, Wang H, Wang X, Wu J, Yin Y, Zhang Q, Chen J, Che W, Chen X, Chen Z, Fu P, Geng C, Guo B, et al. Guidelines of Chinese Society of Clinical Oncology (CSCO) on Diagnosis and Treatment of Breast Cancer (2020 version) Translational Breast Cancer Research. 1: 27-27. DOI: 10.21037/tbcr-2020-2 |
0.152 |
|
| 2016 |
Zhang Q, Shao Z, Shen K, Li L, Feng J, Tong Z, Gu K, Wang X, Xu B, Sun G, Chen H, Rukazenkov Y, Jiang Z. Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China. Oncotarget. PMID 27359058 DOI: 10.18632/oncotarget.10254 |
0.151 |
|
| 2020 |
Xu F, Wang X, Jiang Z. Erratum to a right atrium metastasis of breast cancer after long-term endocrine therapy. Annals of Translational Medicine. 8: 659. PMID 32566596 DOI: 10.21037/atm-2020-22 |
0.15 |
|
| 2016 |
Li H, Rugo HS, Zhang J, Shao Z, Shen Z, Xu B, Wu J, Jiang Z, Song E, Liu Y, Hu X, Geng C, Li B, Tang J, Feng J, et al. Interpreting Advanced Breast Cancer Consensus Guidelines for Use in China Journal of Global Oncology. 2: 36s-37s. DOI: 10.1200/JGO.2016.004028 |
0.15 |
|
| 2007 |
Xu B, Jiang Z, Kim S, Yu S, Feng J, Malzyner A, Giglio AD, Chung H, Yu M, Serrano A. Randomized phase II study of biweekly gemcitabine (gem)-paclitaxel (pac), gem-carboplatin (carb) and gem-cisplatin (cis) as first-line treatments in metastatic breast cancer (MBC) after anthracycline failure Journal of Clinical Oncology. 25: 1099-1099. DOI: 10.1200/JCO.2007.25.18_SUPPL.1099 |
0.149 |
|
| 2020 |
Xu F, Jiang Z. Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer. Annals of Translational Medicine. 8: 138. PMID 32176221 DOI: 10.21037/atm.2019.12.50 |
0.149 |
|
| 2020 |
Xu F, Jiang Z. Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer. Annals of Translational Medicine. 8: 658. PMID 32566595 DOI: 10.21037/atm-2020-21 |
0.149 |
|
| 2005 |
LIU X, SONG S, JIANG Z, LI W, WANG W, YANG H. Clinical Trial of Letrozole (femara) versus Aminoglutethimide in Postmenopausal Women with Advanced Breast Cancer The Chinese-German Journal of Clinical Oncology. 4: 338-340. DOI: 10.1007/s10330-005-0387-4 |
0.149 |
|
| 2021 |
Nie H, Yuan Y, Li J, Xu F, Wang T, Bian L, Jiang Z, Zhang S. Occurrence and distribution of bone metastases in 984 metastatic breast cancer patients Translational Breast Cancer Research. 2: 4-4. DOI: 10.21037/TBCR-20-64 |
0.149 |
|
| 2019 |
Liu J, Jiang Z, Li Q, Li Y, Liu Q, Song E. Efficacy and safety of anti-PD-1 antibody SHR-1210 combined with apatinib in patients with advanced triple-negative breast cancer. Journal of Clinical Oncology. 37: 1066-1066. DOI: 10.1200/JCO.2019.37.15_SUPPL.1066 |
0.147 |
|
| 2018 |
Sun C, Yang F, Zhang Y, Chu J, Wang J, Wang Y, Zhang Y, Li J, Li Y, Fan R, Li W, Huang X, Wu H, Fu Z, Jiang Z, et al. tRNA-Derived Fragments as Novel Predictive Biomarkers for Trastuzumab-Resistant Breast Cancer. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 49: 419-431. PMID 30153663 DOI: 10.1159/000492977 |
0.143 |
|
| 2016 |
Xu F, Bian L, Zhou Y, Du G, Li J, Wang T, Zhang S, Song S, Jiang Z. Germline mutation in the KLRC2 gene to inform intrinsic resistance and inferior responses to trastuzumab in breast cancer. Journal of Clinical Oncology. 34: e12078-e12078. DOI: 10.1200/JCO.2016.34.15_SUPPL.E12078 |
0.142 |
|
| 2016 |
Wang R, Jiang Z, Zhang S, Tian J, Wang T, Song S. Bone metabolism markers: Indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer. Clinical and Experimental Pharmacology & Physiology. PMID 27716993 DOI: 10.1111/1440-1681.12673 |
0.141 |
|
| 2016 |
Wang J, Liu X, Jiang Z, Li L, Cui Z, Gao Y, Kong D, Liu X. A novel method to limit breast cancer stem cells in states of quiescence, proliferation or differentiation: Use of gel stress in combination with stem cell growth factors. Oncology Letters. 12: 1355-1360. PMID 27446437 DOI: 10.3892/ol.2016.4757 |
0.141 |
|
| 2018 |
Bian L, Zhang H, Wang T, Zhang S, Li J, Song H, Xu M, Yao S, Jiang Z. A phase I study of JS001, a humanized PD-1mAbin patients with advanced triple negative breast cancer. Journal of Clinical Oncology. 36: e15093-e15093. DOI: 10.1200/JCO.2018.36.15_SUPPL.E15093 |
0.14 |
|
| 2012 |
Lu Y, Li J, Cheng D, Parameswaran B, Zhang S, Jiang Z, Yew PR, Peng J, Ye Q, Hu Y. The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation. The Journal of Biological Chemistry. 287: 41014-22. PMID 23086937 DOI: 10.1074/Jbc.M112.407106 |
0.139 |
|
| 2020 |
Ma L, Mi Y, Cui S, Wang H, Fu P, Yin Y, Jin F, Li J, Liu Y, Fan Z, Zhang H, Geng C, Jiang Z. Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China. Scientific Reports. 10: 18132. PMID 33093581 DOI: 10.1038/s41598-020-75119-0 |
0.138 |
|
| 2018 |
Jiang Z, Xu F, Sepúlveda M, Li J, Wang H, Liu Z, Yin Y, Yan M, Song Y, Guo J, Roebuck MC, Geng C, Tang J. Concordance, decision impact and guidelines adherence using artificial intelligence in high-risk breast cancer. Journal of Clinical Oncology. 36: e18566-e18566. DOI: 10.1200/JCO.2018.36.15_SUPPL.E18566 |
0.137 |
|
| 2014 |
Hu X, Zhang J, Xu B, Jiang Z, Ragaz J, Tong Z, Zhang Q, Wang X, Feng J, Pang D, Fan M, Li J, Wang B, Wang Z, Zhang Q, et al. Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer. International Journal of Cancer. Journal International Du Cancer. 135: 1961-9. PMID 24604288 DOI: 10.1002/ijc.28829 |
0.137 |
|
| 2013 |
Bian L, Wang T, Zhang S, Jiang Z. Trastuzumab plus capecitabine vs. lapatinib plus capecitabine in patients with trastuzumab resistance and taxane-pretreated metastatic breast cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 34: 3153-8. PMID 23729232 DOI: 10.1007/s13277-013-0884-y |
0.136 |
|
| 2012 |
Ferre P, Shao Z, Jiang Z, Zhong D, Xiaoyan C, Burillon J, Petain A, Zorza G, Zhang L. Is vinorelbine pharmacokinetics modified in Asian patients when compared to caucasian patients? Journal of Clinical Oncology. 30: e13036-e13036. DOI: 10.1200/JCO.2012.30.15_SUPPL.E13036 |
0.134 |
|
| 2016 |
Xu F, Wang X, Jiang Z. The way to precision medicine of our team. Chinese Clinical Oncology. PMID 27197515 DOI: 10.21037/cco.2016.05.03 |
0.134 |
|
| 2020 |
Xu F, Sepúlveda MJ, Jiang Z, Wang H, Li J, Liu Z, Yin Y, Roebuck MC, Shortliffe EH, Yan M, Song Y, Geng C, Tang J, Purcell Jackson G, Preininger AM, et al. Effect of an Artificial Intelligence Clinical Decision Support System on Treatment Decisions for Complex Breast Cancer. Jco Clinical Cancer Informatics. 4: 824-838. PMID 32970484 DOI: 10.1200/CCI.20.00018 |
0.131 |
|
| 2016 |
Fu HD, Qian GL, Jiang ZY. Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. PMID 27489255 DOI: 10.1136/jim-2016-000163 |
0.126 |
|
| 2003 |
Feng J, Yan J, Chen J, Schlake G, Jiang Z, Buzin CH, Sommer SS, Dritschilo A. Absence of somatic ATM missense mutations in 58 mammary carcinomas. Cancer Genetics and Cytogenetics. 145: 179-82. PMID 12935933 DOI: 10.1016/S0165-4608(03)00120-1 |
0.126 |
|
| 2016 |
Meng Q, Xing Y, Ren T, Lu H, Xi Y, Jiang Z, Hu J, Li C, Sun L, Sun D, Cai L. Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition. Oncotarget. PMID 27531895 DOI: 10.18632/oncotarget.11220 |
0.121 |
|
| 2016 |
Jiang Z, Shao Z, Zhang Q, Yao Y, He J, Liao W, Qin S, Cheng Y, Xu Y, Dong J, Zhang L. Efficacy and safety of denosumab from a phase III, randomized, active-controlled study compared with zoledronic acid in patients of Asian ancestry with bone metastases from solid tumors. Journal of Clinical Oncology. 34: 10116-10116. DOI: 10.1200/JCO.2016.34.15_SUPPL.10116 |
0.118 |
|
| 2016 |
Yang L, Huang M, Zhang R, Lv J, Ren Y, Jiang Z, Zhang W, Luan X. Reconstructing the historical distribution of the Amur Leopard (Panthera pardus orientalis) in Northeast China based on historical records. Zookeys. 143-53. PMID 27408548 DOI: 10.3897/zookeys.592.6912 |
0.114 |
|
| 2016 |
Zhang J, Han G, Jiang Z, Wang D. [Analysis of metastatic patterns after curative colorectal cancer surgery based on primary tumor location]. Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery. 19: 780-4. PMID 27452756 |
0.112 |
|
| 2021 |
Zhu J, Jiao D, Yan M, Chen X, Wang C, Lu Z, Li L, Sun X, Qin L, Guo X, Zhang C, Qiao J, Li J, Fan Z, Wang H, ... ... Jiang Z, et al. Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer. Frontiers in Oncology. 11: 675070. PMID 33996607 DOI: 10.3389/fonc.2021.675070 |
0.11 |
|
| 2021 |
Jiang Z, Wang H, Wang S, Wang S, Wang T, Wang X, Feng J, Liu J, Liu Q, Sun T, Yan M, Zhang Q, Chen J, Ouyang Q, Hu X, et al. Chinese expert consensus statement on the clinical diagnosis and treatment of breast cancer bone metastasis and bone related disease Translational Breast Cancer Research. 2: 2-2. DOI: 10.21037/TBCR-20-65 |
0.109 |
|
| 2016 |
Mema SC, Yang H, Vaska M, Elnitsky S, Jiang Z. Integrated Cancer Screening Performance Indicators: A Systematic Review. Plos One. 11: e0161187. PMID 27518708 DOI: 10.1371/journal.pone.0161187 |
0.105 |
|
| 2016 |
Li YC, Luo ML, Guo H, Wang TT, Lin SR, Chen JB, Ma Q, Gu YL, Jiang ZM, Gui YT. Identification of NR0B1 as a novel androgen receptor co-repressor in mouse Sertoli cells. International Journal of Molecular Medicine. PMID 27431683 DOI: 10.3892/ijmm.2016.2672 |
0.105 |
|
| 2012 |
Song Y, Wang J, Yu X, Song S, Jiang Z. Expression of proto-oncogene Fra-1 in human neoplastic breast tissues The Chinese-German Journal of Clinical Oncology. 11: 332-335. DOI: 10.1007/S10330-012-0984-Y |
0.104 |
|
| 2016 |
Gao F, Cui Y, Jiang H, Sui D, Wang Y, Jiang Z, Zhao J, Lin S. Circulating tumor cell is a common property of brain glioma and promotes the monitoring system. Oncotarget. PMID 27517490 DOI: 10.18632/oncotarget.11114 |
0.103 |
|
| 2016 |
Wang Y, Zhao Y, Herbst A, Kalinski T, Qin J, Wang X, Jiang Z, Benedix F, Franke S, Wartman T, Camaj P, Halangk W, Kolligs FT, Jauch KW, Nelson PJ, et al. miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression. Annals of Surgery. PMID 27501171 DOI: 10.1097/SLA.0000000000001928 |
0.099 |
|
| 2016 |
Du HG, Wei H, Jiang Z, Wang HM, Ye SL, Song HQ, Ning XT. [Case-control study on three spinal rotation manipulations for the treatment of lumbar disc herniation]. Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology. 29: 444-8. PMID 27505962 |
0.098 |
|
| 2016 |
Li W, Zhang L, Chen X, Jiang Z, Zong L, Ma Q. Hyperglycemia Promotes the Epithelial-Mesenchymal Transition of Pancreatic Cancer via Hydrogen Peroxide. Oxidative Medicine and Cellular Longevity. 2016: 5190314. PMID 27433288 DOI: 10.1155/2016/5190314 |
0.098 |
|
| 2010 |
Zhang L, Yu S, Xie G, Xu B, Jiang Z, Lu S, Wang H, Sun Y. A large, multicenter, retrospective epidemiological survey: The incidence and treatment of bone metastatic disease in Chinese cancer patients. Journal of Clinical Oncology. 28: e19612-e19612. DOI: 10.1200/jco.2010.28.15_suppl.e19612 |
0.098 |
|
| 2016 |
Guan X, Chen W, Liu Z, Jiang Z, Hu H, Zhao Z, Wang S, Chen Y, Wang G, Wang X. Whether regional lymph nodes evaluation should be equally required for both right and left colon cancer. Oncotarget. PMID 27494866 DOI: 10.18632/oncotarget.11007 |
0.097 |
|
| 2016 |
Lu M, Zhou HS, You QD, Jiang Z. Design, Synthesis, and Initial Evaluation of Affinity-based Small-Molecule Probes for Fluorescent Visualization and Specific Detection of Keap1. Journal of Medicinal Chemistry. PMID 27409246 DOI: 10.1021/acs.jmedchem.6b00775 |
0.097 |
|
| 2016 |
Jiang Z, Liu Y, Wang C. Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer - SGC-7901cell line. Oncotargets and Therapy. 9: 4859-66. PMID 27563247 DOI: 10.2147/OTT.S97861 |
0.096 |
|
| 2016 |
Song HT, Gao Y, Yang YM, Xiao WJ, Liu SH, Xia WC, Liu ZL, Yi L, Jiang ZB. Synergistic effect of cellulase and xylanase during hydrolysis of natural lignocellulosic substrates. Bioresource Technology. 219: 710-715. PMID 27560367 DOI: 10.1016/j.biortech.2016.08.035 |
0.095 |
|
| 2016 |
Fan D, Parhira S, Zhu GY, Jiang ZH, Bai LP. Triterpenoids from the stems of Tripterygium regelii. Fitoterapia. PMID 27425447 DOI: 10.1016/j.fitote.2016.07.006 |
0.095 |
|
| 2016 |
Shao J, Zhou S, Jiang Z, Chi T, Ma J, Kuo M, Lee AY, Jia L. Warfarin and coumarin-like Murraya paniculata extract down-regulate EpCAM-mediated cell adhesion: individual components versus mixture for studying botanical metastatic chemopreventives. Scientific Reports. 6: 30549. PMID 27480614 DOI: 10.1038/srep30549 |
0.091 |
|
| 2007 |
Zhang H, Wang X, Li J, Zhu J, Xie X, Yuan B, Yang Z, Zeng M, Jiang Z, Li J, Huang C, Ye Q. Tissue type-specific modulation of ER transcriptional activity by NFAT3. Biochemical and Biophysical Research Communications. 353: 576-81. PMID 17194453 DOI: 10.1016/j.bbrc.2006.12.046 |
0.091 |
|
| 2016 |
Jiang Z, Liu Z, Zou S, Ni J, Shen L, Zhou Y, Hua D, Wu S. Transcription factor c-jun regulates β3Gn-T8 expression in gastric cancer cell line SGC-7901. Oncology Reports. PMID 27459970 DOI: 10.3892/or.2016.4959 |
0.089 |
|
| 2016 |
Chen Z, Zhang X, Jiang Z, Chen X, He H, Zhang X. Light/dark cycle of microalgae cells in raceway ponds: Effects of paddlewheel rotational speeds and baffles installation. Bioresource Technology. 219: 387-391. PMID 27504995 DOI: 10.1016/j.biortech.2016.07.108 |
0.088 |
|
| 2015 |
Song M, Jiang Z. Inferring Association between Compound and Pathway with an Improved Ensemble Learning Method. Molecular Informatics. 34: 753-760. PMID 27491036 DOI: 10.1002/minf.201500033 |
0.086 |
|
| 2016 |
Wang Z, Jiang Z, Chen Y. Single-shot dual-wavelength phase reconstruction in off-axis digital holography with polarization-multiplexing transmission. Applied Optics. 55: 6072-6078. PMID 27505390 |
0.086 |
|
| 2016 |
Lu H, Wang T, Li J, Fedele C, Liu Q, Zhang J, Jiang Z, Jain D, Iozzo RV, Violette SM, Weinreb PH, Davis RJ, Gioeli D, Fitzgerald TJ, Altieri DC, et al. αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer Through JNK1-Mediated Activation of Androgen Receptor. Cancer Research. PMID 27450452 DOI: 10.1158/0008-5472.Can-16-0543 |
0.084 |
|
| 2016 |
Wei J, Yang Y, Lu M, Lei Y, Xu L, Jiang Z, Xu X, Guo X, Zhang X, You Q, Sun H. Recent Advances in the Discovery of HIF- 1α/p300 Inhibitors as Anti-cancer Agents. Mini Reviews in Medicinal Chemistry. PMID 27484627 DOI: 10.2174/1389557516666160630124938 |
0.083 |
|
| 2016 |
Chen J, Gu Y, Zhang Z, Zheng W, Yang L, Huang W, Lin S, Li Y, Guo H, Luo M, Ma Q, Jiang Z, Tang A, Gui Y. Deficiency of SPATA46, a Novel Nuclear Membrane Protein, Causes Subfertility in Male Mice. Biology of Reproduction. PMID 27488028 DOI: 10.1095/biolreprod.116.140996 |
0.078 |
|
| 2016 |
Wang G, Liu M, Wang H, Yu S, Jiang Z, Sun J, Han K, Shen J, Zhu M, Lin Z, Jiang C, Guo M. Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway. Journal of Cancer. 7: 1431-40. PMID 27471559 DOI: 10.7150/jca.15497 |
0.078 |
|
| 2012 |
Liu G, Yang W, Guo M, Liu X, Huang N, Li D, Jiang Z, Yang W, Zhang W, Su H, Liu Z, Liu T, Wang D, Huang S, Yao B, et al. Effective modulation of CD4(+)CD25 (+high) regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2. Cancer Immunology, Immunotherapy : Cii. 61: 2357-66. PMID 22722448 DOI: 10.1007/s00262-012-1297-2 |
0.077 |
|
| 2020 |
Jiang Z, Tang ET, Li C, Zhu L, Zhang B, Glennane T, Zhang L. What is the relationship between bone turnover markers and skeletal-related events in patients with bone metastases from solid tumors and in patients with multiple myeloma? A systematic review and meta-regression analysis. Bone Reports. 12: 100272. PMID 32420416 DOI: 10.1016/j.bonr.2020.100272 |
0.076 |
|
| 2016 |
Tsuji Y, Okumura T, Kitahara M, Jiang Z. Estimated Seed Shadow Generated by Japanese Martens(Martes melampus): Comparison with Forest-Dwelling Animals in Japan. Zoological Science. 33: 352-7. PMID 27498794 DOI: 10.2108/zs160017 |
0.074 |
|
| 2016 |
Xue MM, Huang CC, Yuan Y, Cui LS, Li Y, Wang B, Jiang ZQ, Fung MK, Liao L. De Novo Design of Boron-Based Host Materials for Highly Efficient Blue and White Phosphorescent OLEDs with Low Efficiency Roll-Off. Acs Applied Materials & Interfaces. PMID 27438586 DOI: 10.1021/acsami.6b05064 |
0.074 |
|
| 2016 |
Wu DW, Liang QL, Zhang XL, Jiang Z, Fan XH, Yue W, Wu QN. New isocoumarin and stilbenoid derivatives from the tubers of Sparganium stoloniferum (Buch.-Ham.). Natural Product Research. 1-7. PMID 27500418 DOI: 10.1080/14786419.2016.1217206 |
0.069 |
|
| 2016 |
Ye W, Jiang Z, Lu X, Ren X, Deng M, Lin S, Xiao Y, Lin S, Wang S, Li B, Zheng Y, Lai P, Weng J, Wu D, Ma Y, et al. GZD824 suppresses the growth of human B cell precursor acute lymphoblastic leukemia cells by inhibiting the SRC kinase and PI3K/AKT pathways. Oncotarget. PMID 27486875 DOI: 10.18632/oncotarget.10881 |
0.068 |
|
| 2016 |
Liu D, Jiang Z, Wang M, Yang X, Liu H, Chen M, Moorefield CN, Newkome GR, Li X, Wang P. 3D helical and 2D rhomboidal supramolecules: stepwise self-assembly and dynamic transformation of terpyridine-based metallo-architectures. Chemical Communications (Cambridge, England). PMID 27414490 DOI: 10.1039/C6Cc04482D |
0.068 |
|
| 2016 |
Liu Y, Gu Y, Han Y, Zhang Q, Jiang Z, Zhang X, Huang B, Xu X, Zheng J, Cao X. Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils. Cancer Cell. 30: 243-256. PMID 27505671 DOI: 10.1016/J.Ccell.2016.06.021 |
0.065 |
|
| 2016 |
Wang T, Zhang L, Hu J, Duan Y, Zhang M, Lin J, Man W, Pan X, Jiang Z, Zhang G, Gao B, Wang H, Sun D. Mst1 participates in the atherosclerosis progression through macrophage autophagy inhibition and macrophage apoptosis enhancement. Journal of Molecular and Cellular Cardiology. PMID 27496379 DOI: 10.1016/j.yjmcc.2016.08.002 |
0.062 |
|
| 2016 |
Jiang Z, Xu G, Jing Y, Tang W, Lin R. Phytochrome B and REVEILLE1/2-mediated signalling controls seed dormancy and germination in Arabidopsis. Nature Communications. 7: 12377. PMID 27506149 DOI: 10.1038/ncomms12377 |
0.06 |
|
| 2016 |
Wang L, Jiang Z, Chen BB, Wang CT, Wang JX, Bai J, Wang B, Jin L, Zhang WJ, Deng YC, Zhao G, Dang JX, Wang D, Jia SS, Wang TC, et al. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China. Epilepsy & Behavior : E&B. 62: 204-208. PMID 27494356 DOI: 10.1016/j.yebeh.2016.07.011 |
0.059 |
|
| 2016 |
Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, Tian W. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Molecular Medicine Reports. PMID 27432616 DOI: 10.3892/mmr.2016.5508 |
0.059 |
|
| 2016 |
Zhang H, Pluhackova K, Jiang Z, Böckmann RA. Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to Assisted Release Mechanism via the ApoM Calyx-Opening. Scientific Reports. 6: 30655. PMID 27476912 DOI: 10.1038/srep30655 |
0.059 |
|
| 2019 |
Wang T, Zhou J, Zhang S, Bian L, Hu Z, Jiang Z. Dynamic change of PD-L1 expression on circulating tumor cells in advanced breast cancer undergoing PD-1 blockade therapy. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E14558 |
0.058 |
|
| 2016 |
Xu W, Jiang Z, Zhao Q, Zhang Z, Su H, Gao X, Ye Z. Acute toxicity assessment of explosive-contaminated soil extracting solution by luminescent bacteria assays. Environmental Science and Pollution Research International. PMID 27566156 DOI: 10.1007/s11356-016-7492-5 |
0.058 |
|
| 2016 |
Vathipadiekal V, Farrell JJ, Wang S, Edward HL, Shappell H, Al-Rubaish AM, Al-Muhanna F, Naserullah Z, Alsuliman A, Qutub HO, Simkin I, Farrer LA, Jiang Z, Luo HY, Huang S, et al. A Candidate Trans-acting Modulator of Fetal Hemoglobin Gene Expression in the Arab-Indian Haplotype of Sickle Cell Anemia: -ANTXR1 Variants and HbF. American Journal of Hematology. PMID 27501013 DOI: 10.1002/Ajh.24527 |
0.058 |
|
| 2016 |
He YM, Deng HH, Shi MH, Bodinga BM, Chen HL, Han ZS, Jiang ZL, Li QW. Melatonin modulates the functions of porcine granulosa cells via its membrane receptor MT2 in vitro. Animal Reproduction Science. PMID 27477115 DOI: 10.1016/j.anireprosci.2016.07.015 |
0.058 |
|
| 2016 |
Wang Y, Cai J, Wu M, Zhang H, Meng M, Tian Y, Ding T, Gong J, Jiang Z, Li X. Hydrogenated Cage-like Titania Hollow Spherical Photocatalysts for Hydrogen Evolution under Simulated Solar Light Irradiation. Acs Applied Materials & Interfaces. PMID 27500415 DOI: 10.1021/Acsami.6B05777 |
0.056 |
|
| 2016 |
Wang X, Wang X, Yu W, Jiang Z, Mao D. Acoustic performance of boundaries having constant phase gradient. The Journal of the Acoustical Society of America. 140: EL7. PMID 27475215 DOI: 10.1121/1.4954754 |
0.055 |
|
| 2016 |
Tian WL, Jiang ZX, Wang F, Guo R, Tang P, Huang YM, Sun L. IRF3 is involved in human acute myeloid leukemia through regulating the expression of miR-155. Biochemical and Biophysical Research Communications. PMID 27530922 DOI: 10.1016/j.bbrc.2016.08.080 |
0.053 |
|
| 2016 |
Li Y, Xia G, Guo Q, Wu L, Chen S, Yang Z, Wang W, Zhang ZY, Zhou X, Jiang ZX. Design, synthesis and evaluation of novel (19)F magnetic resonance sensitive protein tyrosine phosphatase inhibitors. Medchemcomm. 7: 1672-1680. PMID 27529021 DOI: 10.1039/C6Md00277C |
0.053 |
|
| 2016 |
Liu T, Yang S, Jiang Z. Electromagnetic exploration of far-field super-focusing nanostructured metasurfaces. Optics Express. 24: 16297-16308. PMID 27464083 |
0.053 |
|
| 2016 |
Lao T, Jiang Z, Yun J, Qiu W, Guo F, Huang C, Mancini JD, Gupta K, Laucho-Contreras ME, Naing ZZ, Zhang L, Perrella MA, Owen CA, Silverman EK, Zhou X. Hhip haploinsufficiency sensitizes mice to age-related emphysema. Proceedings of the National Academy of Sciences of the United States of America. PMID 27444019 DOI: 10.1073/Pnas.1602342113 |
0.051 |
|
| 2016 |
Zhao Y, Zheng H, Xu A, Yan D, Jiang Z, Qi Q, Sun J. Analysis of codon usage bias of envelope glycoprotein genes in nuclear polyhedrosis virus (NPV) and its relation to evolution. Bmc Genomics. 17: 677. PMID 27558469 DOI: 10.1186/s12864-016-3021-7 |
0.051 |
|
| 2016 |
Meng J, Jiang Z, Wang LV, Park J, Kim C, Sun M, Zhang Y, Song L. High-speed, sparse-sampling three-dimensional photoacoustic computed tomography in vivo based on principal component analysis. Journal of Biomedical Optics. 21: 76007. PMID 27424604 DOI: 10.1117/1.JBO.21.7.076007 |
0.051 |
|
| 2016 |
Dai G, Jiang Z, Zhu L, Zhang Q, Zong Y, Liu S, Li C, Ju W. Simultaneous determination of notoginsenoside R1 and ginsenoside Re in rat plasma by ultra high performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study. Journal of Separation Science. PMID 27412519 DOI: 10.1002/jssc.201600522 |
0.05 |
|
| 2016 |
Wang X, Wang Y, Feng L, Tong Y, Chen Z, Ying S, Chen T, Li T, Xia H, Jiang Z, Shang Q, Lou X, Lou J. Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China. Plos One. 11: e0161240. PMID 27537182 DOI: 10.1371/journal.pone.0161240 |
0.048 |
|
| 2016 |
Zhao C, Jiang Z, Mu R, Li Y. A novel sensor for dopamine based on the turn-on fluorescence of Fe-MIL-88 metal-organic frameworks-hydrogen peroxide-o-phenylenediamine system. Talanta. 159: 365-70. PMID 27474319 DOI: 10.1016/j.talanta.2016.06.043 |
0.048 |
|
| 2016 |
Zhao X, Gao F, Zhang X, Wang Y, Xu L, Liu K, Zhao X, Chang Y, Wei H, Chen H, Chen Y, Jiang Z, Huang X. Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study. Science China. Life Sciences. PMID 27535422 DOI: 10.1007/s11427-016-0014-8 |
0.048 |
|
| 2015 |
Spraggs CF, Parham LR, Warren L, Williams LS, Briley LP, Fraser D, Jiang Z, Aziz Z, Tong Z, Moodley SD, Mehta AO, Jackson N, Byrne J, Andersson M, Toi M, et al. HLA-DRB1*07:01 biomarker characterization of hepatotoxicity during lapatinib combination therapies in ALTTO. Journal of Clinical Oncology. 33: 617-617. DOI: 10.1200/JCO.2015.33.15_SUPPL.617 |
0.047 |
|
| 2005 |
Cohn JA, Neoptolemos JP, Feng J, Yan J, Jiang Z, Greenhalf W, McFaul C, Mountford R, Sommer SS. Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers Human Mutation. 26: 303-307. PMID 16134171 DOI: 10.1002/humu.20232 |
0.047 |
|
| 2021 |
Xu M, Guo L, Du X, Li L, Peters BA, Deng L, Wang O, Chen F, Wang J, Jiang Z, Han J, Ni M, Yang H, Xu X, Liu X, et al. Accurate Haplotype-Resolved Assembly Reveals The Origin Of Structural Variants For Human Trios. Bioinformatics (Oxford, England). PMID 33538292 DOI: 10.1093/bioinformatics/btab068 |
0.047 |
|
| 2016 |
Li Y, Jiang Z, Wang M, Yuan J, Liu D, Yang X, Chen M, Yan J, Li X, Wang P. Giant, Hollow 2D Metallo-Architecture: Step-Wise Self-Assembly of Hexagonal Supramolecular Nut. Journal of the American Chemical Society. PMID 27447878 DOI: 10.1021/jacs.6b06021 |
0.046 |
|
| 2016 |
Wang X, Jiang Z, Chen B, Zhou L, Kong Z, Zuo S, Liu H, Yin S. Cardiac autonomic function in patients with acute exacerbation of chronic obstructive pulmonary disease with and without ventricular tachycardia. Bmc Pulmonary Medicine. 16: 124. PMID 27544078 DOI: 10.1186/s12890-016-0287-0 |
0.046 |
|
| 2016 |
Li XJ, Liu SW, Jiang ZK, Wu G, Sun CH. Hoyosella rhizosphaerae sp. nov., a novel halotolerant actinobacterium isolated from rhizosphere soil of Suaeda salsa and emended description of the genus Hoyosella. International Journal of Systematic and Evolutionary Microbiology. PMID 27515094 DOI: 10.1099/ijsem.0.001416 |
0.046 |
|
| 2016 |
Zhou X, Meng X, Liu Z, Chang J, Wang B, Li M, Wengel PO, Tian S, Wen C, Wang Z, Garber PA, Pan H, Ye X, Xiang Z, Bruford MW, ... Jiang Z, et al. Population Genomics Reveals Low Genetic Diversity and Adaptation to Hypoxia in Snub-Nosed Monkeys. Molecular Biology and Evolution. 33: 2670-81. PMID 27555581 DOI: 10.1093/Molbev/Msw150 |
0.045 |
|
| 2016 |
Zhang K, Zhou W, Chi L, Zhang X, Hu W, Jiang B, Pan K, Tian G, Jiang Z. Black N/H-TiO2 Nanoplates with a Flower-Like Hierarchical Architecture for Photocatalytic Hydrogen Evolution. Chemsuschem. PMID 27552078 DOI: 10.1002/cssc.201600854 |
0.045 |
|
| 2016 |
Bai W, Jiang Z, Ribbe AE, Thayumanavan S. Smart Organic Two-Dimensional Materials Based on a Rational Combination of Non-covalent Interactions. Angewandte Chemie (International Ed. in English). PMID 27490155 DOI: 10.1002/Anie.201605050 |
0.045 |
|
| 2016 |
Jiao Y, Jiang Z, Wu Y, Chen X, Xiao X, Yu H. A Functional Polymorphism (rs937283) in the MDM2 Promoter Region is Associated with Poor Prognosis of Retinoblastoma in Chinese Han Population. Scientific Reports. 6: 31240. PMID 27506496 DOI: 10.1038/srep31240 |
0.045 |
|
| 2016 |
Minami M, Konishi T, Jiang Z, Arai T, Makino T. Effect of Shin'iseihaito on murine allergic reaction induced by nasal sensitization. Journal of Traditional and Complementary Medicine. 6: 252-6. PMID 27419089 DOI: 10.1016/j.jtcme.2015.06.001 |
0.044 |
|
| 2016 |
Zhang R, Liu Y, He M, Su Y, Zhao X, Elimelech M, Jiang Z. Antifouling membranes for sustainable water purification: strategies and mechanisms. Chemical Society Reviews. PMID 27494001 DOI: 10.1039/C5Cs00579E |
0.044 |
|
| 2016 |
Guo H, Jiang Z, Song S, Dai T, Wang X, Sun K, Zhou G, Dou H. Structural regulation of self-assembled iron oxide/polymer microbubbles towards performance-tunable magnetic resonance/ultrasonic dual imaging agents. Journal of Colloid and Interface Science. 482: 95-104. PMID 27497230 DOI: 10.1016/j.jcis.2016.07.042 |
0.043 |
|
| 2016 |
Qi X, Li H, Cong X, Wang X, Jiang Z, Cao R, Tian W. Baicalin increases developmental competence of mouse embryos in vitro by inhibiting cellular apoptosis and modulating HSP70 and DNMT expression. The Journal of Reproduction and Development. PMID 27478062 DOI: 10.1262/jrd.2016-047 |
0.043 |
|
| 2016 |
Zhu T, Mahdy MR, Cao Y, Lv H, Sun F, Jiang Z, Ding W. Optical pulling using evanescent mode in sub-wavelength channels. Optics Express. 24: 18436-18444. PMID 27505807 |
0.043 |
|
| 2016 |
Yang LL, Jiang Z, Tang SK, Chu X, Xu LH, Zhi XY. Yimella radicis sp. nov., an novel endophytic actinobacterium isolated from the root of Paris polyphylla Smith var. yunnanensis. International Journal of Systematic and Evolutionary Microbiology. PMID 27469463 DOI: 10.1099/ijsem.0.001334 |
0.043 |
|
| 2016 |
Jiang Z, Liu Q, Dekkers MJ, Barrón V, Torrent J, Roberts AP. Control of Earth-like magnetic fields on the transformation of ferrihydrite to hematite and goethite. Scientific Reports. 6: 30395. PMID 27458091 DOI: 10.1038/Srep30395 |
0.043 |
|
| 2016 |
Jiang Z, Wang H, Li Y, Hou Z, Ma N, Chen W, Zong Z, Chen S. MiR-129-5p is down-regulated and involved in migration and invasion of gastric cancer cells by targeting interleukin-8. Neoplasma. 63. PMID 27468870 DOI: 10.4149/neo_2016_503 |
0.042 |
|
| 2016 |
Jiang Z, Yu B, Li Y. Effect of Three Statins on Glucose Uptake of Cardiomyocytes and its Mechanism. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 22: 2825-30. PMID 27510725 |
0.041 |
|
| 2016 |
Li T, Jiang Z, Zhang L, Tan D, Wei Y, Yuan H, Li T, Wang A. Apple (Malus domestica) MdERF2 Negatively Affects Ethylene Biosynthesis During Fruit Ripening by Suppressing MdACS1 Transcription. The Plant Journal : For Cell and Molecular Biology. PMID 27476697 DOI: 10.1111/tpj.13289 |
0.041 |
|
| 2016 |
Wan Z, Li Y, Bo S, Gao M, Wang X, Zeng K, Tao X, Li X, Yang Z, Jiang ZX. Amide bond-containing monodisperse polyethylene glycols beyond 10 000 Da. Organic & Biomolecular Chemistry. PMID 27477448 DOI: 10.1039/c6ob01286h |
0.04 |
|
| 2016 |
Liang ZB, Sun YC, Li JH, Wang ZB, Xje ZL, Zhang M, Liao Y, Jiang ZL. [Sources and Variation Characteristics of Dissolved Lipid Biomarkers in a Typical Karst Underground River]. Huan Jing Ke Xue= Huanjing Kexue / [Bian Ji, Zhongguo Ke Xue Yuan Huan Jing Ke Xue Wei Yuan Hui "Huan Jing Ke Xue" Bian Ji Wei Yuan Hui.]. 37: 1814-22. PMID 27506035 |
0.04 |
|
| 2016 |
Zhong W, Jiang ZY, Zhong SB, Zhang LC, Huang JH, Zhang S, Chen LS, Cao YF. [Phenotypic characteristics of LAP(+) CD4(+) T lymphocytes in colorectal cancer tissues]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 38: 596-601. PMID 27531479 |
0.04 |
|
| 2016 |
Liang C, Sun J, Cui X, Jiang Z, Zhang W, Li T. Spinal sagittal imbalance in patients with lumbar disc herniation: its spinopelvic characteristics, strength changes of the spinal musculature and natural history after lumbar discectomy. Bmc Musculoskeletal Disorders. 17: 305. PMID 27444272 DOI: 10.1186/s12891-016-1164-y |
0.037 |
|
| 2016 |
Yuan CG, Jiang Z, Xiao M, Zhou EM, Kim CJ, Hozzein WN, Park DJ, Zhi XY, Li WJ. Mesorhizobium sediminum sp. nov., isolated from the deep-sea sediment of Indian Ocean. International Journal of Systematic and Evolutionary Microbiology. PMID 27535803 DOI: 10.1099/ijsem.0.001432 |
0.036 |
|
| 2010 |
Yu S, Jiang Z, Zhang L, Niu X, Wang L, Wu N, Ma J. Chinese expert consensus statement on clinical diagnosis and treatment of malignant tumor bone metastasis and bone related diseases The Chinese-German Journal of Clinical Oncology. 9: 1-12. DOI: 10.1007/S10330-009-0188-2 |
0.035 |
|
| 2016 |
Ma X, Fang W, Jiang Z, Wang L, Yang X, Gao K. Dibutyryl-cAMP affecting fat deposition of finishing pigs by decreasing the inflammatory system related to insulin sensitive or lipolysis. Genes & Nutrition. 11: 17. PMID 27551318 DOI: 10.1186/s12263-016-0531-5 |
0.035 |
|
| 2017 |
Wen G, Zhang X, Li Y, Luo Y, Liang A, Jiang Z. Highly sensitive determination of antimony in food by resonance Rayleigh scattering-energy transfer between grapheme oxide and I3(.). Food Chemistry. 214: 25-31. PMID 27507443 DOI: 10.1016/j.foodchem.2016.07.050 |
0.035 |
|
| 2016 |
Liu D, Cao H, Jiang Z, Wu T, Sun X, Wang P, Moorefield CN, Dai L, Newkome GR. Mono- and Bis-Terpyridine-Based Dimer and Metallo-Organic Polymers as Ionic Templates for Preparation of Multi-Metallic Au Nanocluster and Nanowires. Journal of Nanoscience and Nanotechnology. 16: 2613-22. PMID 27455678 DOI: 10.1166/Jnn.2016.10831 |
0.033 |
|
| 2016 |
Chen W, Ma X, Lin Y, Xiong Y, Zheng C, Hu Y, Yu D, Jiang Z. Dietary supplementation with a high dose of daidzein enhances the antioxidant capacity in swine muscle but experts pro-oxidant function in liver and fat tissues. Journal of Animal Science and Biotechnology. 7: 43. PMID 27486514 DOI: 10.1186/s40104-016-0102-z |
0.033 |
|
| 2016 |
Du X, Dong C, Wang K, Jiang Z, Chen Y, Yang Y, Chen F, Ni H. Separation and purification of astaxanthin from Phaffia rhodozyma by preparative high-speed counter-current chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1029: 191-197. PMID 27433984 DOI: 10.1016/j.jchromb.2016.06.042 |
0.032 |
|
| 2016 |
Jiang ZC, Li H, Zhu B. A potential mechanism underlying the effects of acupuncture on insulin resistance. Acupuncture in Medicine : Journal of the British Medical Acupuncture Society. PMID 27411703 DOI: 10.1136/acupmed-2016-011190 |
0.032 |
|
| 2016 |
Qiu S, Lee R, Zhu B, Coote ML, Zhao X, Jiang Z. Highly Enantio- and Diastereo-selective [4+2] Cycloaddition of 5H-oxazol-4-ones with N-Maleimides. The Journal of Organic Chemistry. PMID 27459608 DOI: 10.1021/Acs.Joc.6B01451 |
0.032 |
|
| 2016 |
Chen L, Xing H, Zhang H, Jiang ZX, Yang Z. Copper-catalyzed intermolecular chloroazidation of α,β-unsaturated amides. Organic & Biomolecular Chemistry. PMID 27462802 DOI: 10.1039/c6ob01352j |
0.031 |
|
| 2016 |
Hennein L, Hou J, Stewart JM, Lowry EA, Jiang Z, Enanoria WT, Han Y. Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert). Journal of Glaucoma. PMID 27552497 DOI: 10.1097/IJG.0000000000000497 |
0.029 |
|
| 2008 |
Song Y, Qian L, Song S, Chen L, Zhang Y, Yuan G, Zhang H, Xia Q, Hu M, Yu M, Shi M, Jiang Z, Guo N. Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene. Molecular Immunology. 45: 137-43. PMID 17572495 DOI: 10.1016/j.molimm.2007.04.031 |
0.029 |
|
| 2016 |
Sun Q, Zhang B, Yan QJ, Jiang ZQ. Comparative analysis on the distribution of protease activities among fruits and vegetable resources. Food Chemistry. 213: 708-13. PMID 27451238 DOI: 10.1016/j.foodchem.2016.07.029 |
0.029 |
|
| 2016 |
Jiang Z, Jiang J, Wang Y, Zhang E, Zhang Y, Li L, Cai B, Luo Z, Li C, Ping X, Xie F, Cao L. China's ecosystems: Overlooked species. Science (New York, N.Y.). 353: 657. PMID 27516590 DOI: 10.1126/science.aah4000 |
0.028 |
|
| 2016 |
Jiang Z, Wang J, Li X, Zhang X. Echinacoside and Cistanchetubulosa (Schenk) R. Wight ameliorate bisphenol A-induced testicular and sperm damage in rats through gonad axis regulated steroidogenic enzymes. Journal of Ethnopharmacology. PMID 27422164 DOI: 10.1016/j.jep.2016.07.033 |
0.027 |
|
| 2016 |
Yang F, Jiang Z, Miao Y, Yang P. CdS Nanowires with Large Aspect Ratio and Their Composite with CuS and Au Nanoparticles. Journal of Nanoscience and Nanotechnology. 16: 6475-80. PMID 27427739 DOI: 10.1166/jnn.2016.11106 |
0.025 |
|
| 2016 |
Jiang Z, Hua Y. Hydrogen sulfide promotes osteogenic differentiation of human periodontal ligament cells via p38-MAPK signaling pathway under proper tension stimulation. Archives of Oral Biology. 72: 8-13. PMID 27522508 DOI: 10.1016/j.archoralbio.2016.08.008 |
0.022 |
|
| 2016 |
Liu K, Li L, Jiang T, Chen B, Jiang Z, Wang Z, Chen Y, Jiang J, Gu H. Chinese Public Attention to the Outbreak of Ebola in West Africa: Evidence from the Online Big Data Platform. International Journal of Environmental Research and Public Health. 13. PMID 27527196 DOI: 10.3390/ijerph13080780 |
0.022 |
|
| 2016 |
Li KQ, Li J, Wang H, Jiang ZY. [Analysis of microcephaly and related factors among 31 902 infants of Chongqing, China]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]. 50: 625-8. PMID 27412840 DOI: 10.3760/cma.j.issn.0253-9624.2016.07.012 |
0.022 |
|
| 2016 |
Zhao Y, Jiang Z, Tsai WC, Yuan Y, Kroekkiat Chinda D, Choi EK, Fishbein MC, Lin SF, Chen PS, Everett TH. Ganglionated plexi and ligament of Marshall ablation reduces atrial vulnerability and causes stellate ganglion remodeling in ambulatory dogs. Heart Rhythm : the Official Journal of the Heart Rhythm Society. PMID 27426436 DOI: 10.1016/j.hrthm.2016.07.014 |
0.022 |
|
| 2016 |
Wang S, Li X, Guo H, Yuan Z, Wang T, Zhang L, Jiang Z. Emodin alleviates hepatic steatosis by inhibiting SREBP1 activity via the CaMKK-AMPK-mTOR-p70S6K signaling pathway. Hepatology Research : the Official Journal of the Japan Society of Hepatology. PMID 27492505 DOI: 10.1111/hepr.12788 |
0.022 |
|
| 2016 |
Jiang ZC, Jiang RY, Li H, Zhu B. Myokine: a novel target for exercise to improve cognitive function? British Journal of Sports Medicine. PMID 27465697 DOI: 10.1136/bjsports-2016-096513 |
0.019 |
|
| 2016 |
Wang G, Li R, Jiang Z, Gu L, Chen Y, Dai J, Li K. Influenza Virus Induces Inflammatory Response in Mouse Primary Cortical Neurons with Limited Viral Replication. Biomed Research International. 2016: 8076989. PMID 27525278 DOI: 10.1155/2016/8076989 |
0.019 |
|
| 2016 |
Jiang Z, Wang H, Shen Z, Sanvito S, Hou S. Effects of the molecule-electrode interface on the low-bias conductance of Cu-H2-Cu single-molecule junctions. The Journal of Chemical Physics. 145: 044701. PMID 27475380 DOI: 10.1063/1.4959287 |
0.016 |
|
| 2016 |
Jiang Z, Yuan CG, Xiao M, Tian XP, Khan IU, Kim CJ, Zhi XY, Li WJ. Erratum to: Abyssicoccus albus gen. nov., sp. nov., a novel member of the family Staphylococcaceae isolated from marine sediment of the Indian Ocean. Antonie Van Leeuwenhoek. PMID 27499066 DOI: 10.1007/s10482-016-0739-9 |
0.015 |
|
| 2016 |
Zhou J, Jiang Z, Cai W, Liu X, Zhu Y, Lan Y, Ma K, Qian Y. Solvothermal synthesis of a silicon hierarchical structure composed of 20 nm Si nanoparticles coated with carbon for high performance Li-ion battery anodes. Dalton Transactions (Cambridge, England : 2003). PMID 27484803 DOI: 10.1039/C6Dt02551J |
0.015 |
|
| 2016 |
Jiang Z, Chen M, Yu X, Xie Z. 7-Hydroxytropolone produced and utilized as an iron-scavenger by Pseudomonas donghuensis. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 27542164 DOI: 10.1007/s10534-016-9954-0 |
0.01 |
|
| Hide low-probability matches. |